Novo Q2 '20 Roadshow; Provention Bio Q2 '20 Earnings Update; Senseonics Eversense Covered by Highmark
Here is a brief preview of this blast: Novo Nordisk hosted its post-Q2 ’20 earnings roadshow event (see previous FENIX insight on Q2 ’20 Novo earnings from August 6). Additionally, Provention Bio hosted its Q2 '20 earnings call yesterday (press release), and Senseonics announced a positive coverage decision for its implantable CGM from Highmark. Below, FENIX provides highlights and insights from the respective news item and earnings calls.